CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, K. L.
Right arrow Articles by McGuire, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, K. L.
Right arrow Articles by McGuire, C.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 654-659, July 2002
© 2002 American Association for Cancer Research

The Impact of Item Order on Ratings of Cancer Risk Perception1

Kathryn L. Taylor2, Rebecca A. Shelby, Marc D. Schwartz, Josh Ackerman, V. Holland LaSalle, Edward P. Gelmann and Colleen McGuire

Lombardi Cancer Center, Georgetown University, Washington DC 20007-4104

Although perceived risk is central to most theories of health behavior,there is little consensus on its measurement with regard to item wording, response set, or the number of items to include. In a methodological assessment of perceived risk, we assessed the impact of changing the order of three commonly used perceived risk items: quantitative personal risk, quantitative population risk, and comparative risk. Participants were 432 men and women enrolled in an ancillary study of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Three groups of consecutively enrolled participants responded to the three items in one of three question orders. Results indicated that item order was related to the perceived risk ratings of both ovarian (P < 0.05) and colorectal (P < 0.05) cancers. Perceptions of risk were significantly lower when the comparative rating was made first. The findings suggest that compelling participants to consider their own risk relative to the risk of others results in lower ratings of perceived risk. Although the use of multiple items may provide more information than when only a single method is used, different conclusions may be reached depending on the context in which an item is assessed.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Gurmankin Levy, J. Shea, S. V. Williams, A. Quistberg, and K. Armstrong
Measuring perceptions of breast cancer risk.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1893 - 1898.
[Abstract] [Full Text] [PDF]


Home page
Qual Health ResHome page
J. Hay, E. Shuk, G. Cruz, and J. Ostroff
Thinking Through Cancer Risk: Characterizing Smokers' Process of Risk Determination
Qual Health Res, October 1, 2005; 15(8): 1074 - 1085.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. L. Taylor, R. Shelby, E. Gelmann, and C. McGuire
Quality of Life and Trial Adherence Among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
J Natl Cancer Inst, July 21, 2004; 96(14): 1083 - 1094.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.